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ABSTRACT 
Chlorpheniramine maleate is widely used in treatment for 
allergic disorder and cold. The controlled release matrix tablets of 
chlorpheniramine maleate were prepared using HPMC K15M, HPMC 
K100M and carbopol and studied their effect on drug release. 
Prepared tablets were evaluated for various physical parameters. In 
vitro drug release study shows that slow release in HPMC K100M 
than other two polymers. If concentration of polymer increases 
than the drug release is decreases due to formation of polymeric 
matrix. Zero order, first order, Higuchi’s and Korsmeyer’s equations 
applied to know the mechanism of drug release from prepared 
tablets. The similarity and dissimilarity factor found to be 77.88 and 
4.14, respectively for drug release in stability study which shows 
there was no significant difference in drug release.  
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INTRODUCTION 
An allergy is a hypersensitivity disorder of 
the immune system. Allergic reactions occur 
when a person's immune system reacts to 
normally harmless substances in the environ-
ment (Kay, 2001). Chlorpheniramine maleate is 
first-generation alkyl amine antihistamine drug. 
It is widely used in symptomatic relief of 
common cold and allergic diseases. It has also 
been used in veterinary applications. 
Chlorpheniramine maleate is well absorbed in 
the gastrointestinal tract (Sweetman, 2005). 
So formulating matrix tablet of chlorphenira-
mine maleate we can control over allergic 
reaction in the suffering patients.  
These formulations are designed to 
deliver drugs at slow rate over a long time 
period for allergic condition. One of the most 
commonly used methods of developing 
controlled release formulations is to include 
them in matrix tablets. The matrix tablet 
prepared by direct compression is easy to 
manufacture. Using suitable polymer matrix 
formulation is possible and controlled release 
of drug is possible.   
In these study the effect of various 
polymers like HPMC K15M, HPMC K100M 
(Reddy et al., 2003) and carbopol on drug 
release is studied. All the formulation of matrix 
tablets was prepared by direct compression 
method. Drug release kinetics and mechanism 
was calculated for zero order, first-order, 
Higuchi’s and Korsmeyer’s equations 
(Korsmeyer et al., 1983). 
 
MATERIALS AND METHODS  
Chlorpheniramine maleate was received 
as a gift sample from Kon Text Chemicals Ltd,   
Kolkata. HPMC K15M and HPMC K100M 
were gift sample from colorcon India Pvt Ltd. 
Carbopol and MCC (Avicel PH 102) were gift 
sample from Signet Chemical Corporation, 
Mumbai. PVP K30, talc and magnesium 
stearate were procured from Nice Chemicals 
(P) Ltd, Cochin. All other reagents were of 
analytical grade. 
 
Preparation of tablets 
All tablet formulations with different 
drug to polymer ratios were prepared by direct 
compression technique (Formulations M1-M9, 
Table I). All powders were weighed accurately 
in electronic balance then passed separately 
through 60 # screen sieve. Chlorpheniramine 
maleate was first mixed with polymer for           
5min to a mortar and then adds other 
excipients and triturated till it was uniform. 
Rotary eight station punch tablet machine was 
used to press tablets of 120mg weight (Sakr et 
al., 2011). 
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Evaluation of tablets 
Thickness: The thickness of the tablets 
was determined using a vernier caliper. Five 
tablets from each batch were used and the 
average values were calculated. 
Weight variation: To study weight 
variation, 20 tablets of each formulation were 
weighed individually using four digital 
electronic balance (Sartorius bt 224S). 
Drug content: Twenty tablets from each 
batch were weighed accurately and powdered 
powder equivalent to 12mg chlorpheniramine 
maleate was shaken with 100mL of distilled 
water in 100 ml volumetric flask and dilute up 
to appropriate volume. Resulting solution was 
filtered and assayed at 265nm using double 
beem UV/Vis spectrometer (Shimadzu UV-
1800) and content of chlorpheniramine maleate 
was calculated (Praveen, et al., 2011). 
Hardness and friability: For each 
formulation batches, the hardness and friability 
of 5 and 20 tablets, respectively, were 
determined using hardness tester (Monsanto) 
and the friabilator (Electrolab), respectively 
(Indian Pharmacopoeia, 2010). 
Swelling index: This test was used for 
guidance to monitor the development of 
physical changes in the tablets morphology 
when placed in the dissolution medium 
(Sriamornsak, et al., 2007). Tablets are placed 
in the 500 ml distilled water. Weight of tablet 
was determined at zero time, 1.0, 3.0 and 6.0 h 
and calculated swelling index for all batches 
using following equation.  
SI= (W2-W1)/W1*100 
Where SI is swelling index of tablet, W1 is 
initial weight of tablet and W2 is reweigh of 
tablet. 
In vitro release studies: The drug-release 
study was carried out using a USP type-2 
apparatus (Electrolab, TDT-06T) at 37±0.5°C 
and at 50rpm using 900mL of distilled water as 
a dissolution medium (n=3). A sample (5 ml) of 
the solution was withdrawn from the 
dissolution apparatus at half hour interval up to 
8 hour and withdrawn volume was replaced 
with fresh dissolution media. The withdrawn 
samples filtered through a 0.45-micrometer 
membrane filter, diluted suitably, and analyzed 
spectrophotometrically. 
In vitro drug release (kinetics and 
mechanism): To know the mechanism of drug 
release from these formulations, the data were 
fitted to zero order (cumulative amount of drug 
released vs time), first-order (log cumulative 
percentage of drug remaining vs time), 
Higuchi’s (cumulative percentage of drug 
released vs square root of time), and 
Korsmeyer’s (log cumulative percentage of 
drug released vs log time) equations 
(Korsmeyer et al., 1983).  
Zero order equation 
ft= K0t 
Where ft is the fraction dissolved at time 
t and K0 is the apparent dissolution rate 
constant or zero order rate constant. 
First-order equation 
logQt = logQ0 -K1t/2:303 
Where Qt is the amount released at time 
t, Q0 is the initial amount of drug in solution 
and K1 is the first order rate constant. 
Higuchi’s equation 
Ft = KH- t1/2 
Where Ft is the fraction dissolved at time 
t and KH is the Higuchi dissolution constant. 
Korsmeyer’s equation 
Mt/M∞= atn 
Where Mt is the amount of drug released 
at time t, M∞ is the amount of drug released 
after infinite time (total drug in a dosage form), 
a is the Korsmeyer’s dissolution rate constant 
and n is the release exponent. 
Stability study: stability studies were 
conducted on optimized formulation (M6) 
containing HPMC K100M in 41%. Assess their 
stability with respect to their physical 
parameters and drug release characteristics after 
storing them at 40°C with relative humidity 
(RH) 75% for 6 months. 
 
Similarity factor (f2) and difference 
factor (f1) analysis. 
Effect of storage condition on in vitro 
drug release profile of optimized formulation 
(M6) was performed. The similarity factor (f2) 
and difference factor (f1) was determined using 
the data obtained from drug release studies 
(Mukesh, et al., 2005). The data were analyzed 
by the formula shown in following equations. 
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Where n is the number of data points, Rt 
is the amount released from the reference at 
time t, and Tt is the amount released from the 
test at time t. The similarity of two release 
profile can observe using the value of f2 and f1. 
 
RESULTS AND DISCUSSION  
Physical properties of the tablets 
The comparison of physical properties 
of the matrix tablets (Table II). The weight and 
thickness of the matrix tablets ranged from 
118.0 to 123.1mg and 1.88 to 2.01 respectively. 
All tablets prepared in thisstudy meet the 
official pharmacopeia requirements for weight 
variation and uniform thickness. 
Drug uniformity results were found to 
be good among different batches of tablets, and 
the percentage of drug content was more than 
98.32%. 
In the present study, the percentage 
friability for all the formulations was below 1%, 
indicating that the friability is within the 
pharmacopeia limits. The hardness of the tablet 
was found to be 2.4 to 5.6 kg/cm2 which show 
sufficient mechanical strength. 
All the tablet formulations showed 
acceptable pharmacotechnical properties and 
acceptable according to pharmacopoeial 
specifications. 
The swelling index was calculated with 
respect to time (Figure 1). As time increases, 
the swelling index was increased, because 
weight gain by tablet was increased 
proportionally with rate of hydration up to 4h. 
Later on, it decreases gradually due to 
dissolution of outer most gelled layer of tablet 
into dissolution medium. From the graph it 
observed that batch M6 has lower swelling 
index which contain HPMC K100M in around 
41% and batch M7 has higher swelling index 
and rate of hydration which contain carbopol in 
25% concentration. 
The in vitro drug release of all batches is 
show in fig 2, 3 and 4. All the batches shows 
that around 100% drug release are found at 4.5 
Table I. Formulation batches of chlorpheniramine maleate matrix tablet 
 
Ingredients M1 M2 M3 M4 M5 M6 M7 M8 M9 
Chlorpheniramine maleate 12 12 12 12 12 12 12 12 12 
HPMC K15M 30 40 50 - - - - - - 
HPMC K100M - - - 30 40 50 - - - 
carbbopol - - - - - - 30 40 50 
Avicel PH 102 70 60 50 70 60 50 70 60 50 
PVP K30 4 4 4 4 4 4 4 4 4 
talc 2 2 2 2 2 2 2 2 2 
Mg stearate 2 2 2 2 2 2 2 2 2 
 
Table II. Physical properties of the prepared tablets 
 
Batches 
Average 
weight (mg) 
Thickness 
(mm) 
Hardness 
(Kg/cm2) 
Friability 
(%) 
Drug content 
(%) 
M1 118.5 ±2 1.93±0.1 2.4 ±0.37 0.52 98.32 
M2 120.3 ±3 1.98±0.2 3.7 ±0.40 0.34 99.96 
M3 123.1 ±1 2.01±0.1 5.2 ±0.51 0.23 100.40 
M4 119.2 ±2 1.88±0.2 2.8 ±0.24 0.43 99.04 
M5 118.0 ±2 1.95±0.3 4.1 ±0.86 0.33 101.02 
M6 120.6 ±3 1.96±0.1 5.6 ±0.37 0.29 100.04 
M7 120.8 ±1 1.97±0.2 2.3 ±0.40 0.50 98.49 
M8 121.8 ±1 1.94±0.2 2.9 ±0.66 0.43 99.73 
M9 119.9 ±2 1.89±0.3 5.1 ±0.58 0.31 100.24 
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hour onward. The almost drug release found in 
batch M1 and M7 are at 4.5 and 5.5hour due        
to low concentration of polymers that is 
HPMC K15M and carbopol, respectively. 
Batch M6 is consider as a best batch from all 
other batches due to its slow drug release up to 
8hour which contains HPMC K100M in 41% 
concentration. 
To know the mechanism of drug release 
from these tablet formulations, the data were 
treated according to zero order, first-order, 
Higuchi’s plot and Korsmeyer’s plot. As clearly 
indicated in table III, all the formulations 
follow zero order (regression coefficient is 
more than 0.982 and near to 0.99) except batch 
M2 and M4 because the regression coefficient 
is 0.973, 0.969 respectively. The regression 
coefficient for batch M2 and M4 is 0.987 and 
0.991 respectively, according to first order plot. 
When the data were plotted according to the 
Higuchi’s equation value is found to be 0.928 
to 0.980. Drug release pattern can be finding 
out by using the slope value of the Korsmeyer’s 
plot. Fickian diffusion was found in all the 
batches because the slope value is less than 
0.45. 
Table III. Release kinetics of chlorpheniramine maleate from the prepared formulations 
 
 
Korsmeyer plot 
Batch  
Zero order 
(R2)  
First order 
(R2)  
Higuchi plot 
(R2) (R2) Slope (n) 
M1 0.994 0.982 0.974 0.986 0.31 
M2 0.973 0.987 0.931 0.918 0.26 
M3 0.990 0.979 0.970 0.966 0.24 
M4 0.969 0.991 0.928 0.947 0.24 
M5 0.991 0.985 0.969 0.957 0.26 
M6 0.997 0.986 0.974 0.976 0.24 
M7 0.996 0.988 0.980 0.983 0.34 
M8 0.992 0.996 0.966 0.970 0.31 
M9 0.982 0.968 0.956 0.971 0.29 
 
Table IV.  Stability study for physical parameter of optimized batch (M6) 
 
Parameter  At 0 month At 3 month At 6 month 
Drug content 100.04 99.42 98.51 
Hardness 5.6 4.9 4.8 
Friability 0.29 0.33 0.51 
 
 
 
 
Figure 1. Swelling properties of prepared matrix tablets 
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The optimized formulation (M6) was 
further evaluated for stability studies. It was 
suggested that there was no significant changes 
in physical parameters such as hardness, weight 
variation, content uniformity and friability.  In-
vitro drug release profile of optimized batch 
(M6) was shown in figure 5. In addition 
statistically no significant difference was 
observed in the release rate after 6 month. The 
value of similarity factor (f2) was found to be 
77.88 which indicate similarity observed after 6 
month due to value is near to 100.  The value 
of difference factor (f1) was found to be 4.14 
indicating similarity between both drug release.  
 
CONCLUSION 
Matrix tablet of Chlorpheniramine 
maleate was successfully prepared by using 
various synthetic polymers such as HPMC 
K15M, HPMC K100M and carbopol. The 
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Figure 2. Drug release profile of HPMC 
K15M containing tablets 
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Figure 3. Drug release profile of HPMC 
K100M containing tablets 
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Figure 4. Drug release profile of 
carbopol containing tablets 
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direct compression method is suitable for 
formulation of matrix tablets. Among these all 
three polymer HPMC K100M gives slow drug 
release up to 8 h in 41% concentration. 
Carbopol gives fast drug release compared to 
other two polymers. There is no significance 
change of physical parameter and drug release 
profile after stability study of matrix tablets. 
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Figure 5. Comparison of dissolution 
profile of M6 batch before and after 
stability study 
 
